We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

ELEKTA

Elekta develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well a... read more Featured Products: More products

Download Mobile App




Leading US Cancer Center Signs deal to Acquire Multiple Radiotherapy Solutions

By HospiMedica International staff writers
Posted on 11 May 2016
A US technology leader in cancer management has signed a deal to acquire four HDR brachytherapy afterloaders, an Oncology Information System (OIS), active breathing coordinator, comprehensive treatment planning software, and service for both hardware and software.

The internationally recognized cancer center provides cancer care at various locations in the US state of Texas, and collaborates with community hospitals and health systems across the US.

The MD Anderson Cancer Center (Houston, Texas, USA) will acquire Elekta’s (Stockholm, Sweden) Infinity comprehensive image-guided radiation therapy system with Volumetric Modulated Arc Therapy (VMAT). More...
The deal includes High-Dose-Rate (HDR) afterloaders, Oncentra Brachy treatment planning, the MOSAIQ OIS, and the Active Breathing Coordinator.

Elekta is a human care company that develops tools and treatment planning systems for radiation therapy, radiosurgery, brachytherapy, and brain disorders, as well as workflow enhancement software for cancer care. Elekta will book the new order in the fourth quarter of fiscal year 2015-16.

Bill Yaeger, executive VP, North America region at Elekta, said, “As a world-renowned cancer center, MD Anderson has been a technology leader in managing the disease. In addition to being one of the first U.S. medical centers to acquire Elekta’s new Leksell Gamma Knife Icon brain radiosurgery system, MD Anderson is also part of the consortium to develop the world’s first high-field MR-guided linear accelerator. We are proud that it has chosen us again in the expansion of its facilities in Texas. Both organizations share a commitment to quality and the best care possible for patients.”

Related Links:
MD Anderson Cancer Center
Elekta

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.